Inventor · disambiguated record
Soufyan Jerhaoui
Also filed as: JERHAOUI SOUFYAN
0 granted patents·6 pending applications·0 citations·filing 2020–2022
Files withJANSSEN PHARMACEUTICA NV6
Top patents by PatentIndex Score
6 records- 0164US2025051359A1Macrocyclic 2-amino-but-3-enamides as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0257US2024190893A1Macrocyclic 1,3-bridged 6-chloro-7-pyrazol-4-yl-1 h-indole-2-carboxylate and 6-chloro-7-pyrimidin-5-yl-1h-indole-2-carboxylate derivatives as mcl-1 inhibitors for the treatment of cancerJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0356US2024083890A1Macrocyclic branched 3-fluoro-but-3-enamides as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0455US2023219906A1Macrocyclic-2-amino-3-fluoro-but-3-enamides as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0553US2024239812A1Macrocyclic 2-allyltetrahydrofurans as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0651US2024067660A1Macrocyclic spirocycle derivatives as mcl-1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Soufyan Jerhaoui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →